Skydiving

If you’re a thrill seeker, an adrenaline junkie, or purely want to try something out of the ordinary, this could be for you!

Running
Cycling
Overseas
Skydiving
UK Challenges
Virtual Events

1 January 2024 - 31 December 2024

Skydiving

Take on a skydive for blood cancer patients! If you're a budding thrill seeker, an adrenaline junkie or simply want to experience something incredible, a charity skydive could be for you.

1 January 2024 - 31 December 2024

London Events

Find your perfect event in London and raise money for Leukaemia Care

1 January 2024 - 31 December 2024

North East Events

Find a local event in the North East and raise money for Leukaemia Care

1 January 2024 - 31 December 2024

Scotland Events

Find a local running event in Scotland and raise money for Leukaemia Care

1 January 2024 - 31 December 2024

South East Events

Find a local event in the South East and raise money for Leukaemia Care

1 January 2024 - 31 December 2024

South West Events

Find a local event in the South West and raise money for Leukaemia Care

1 January 2024 - 31 December 2024

Adrenaline Challenges

Feel the thrill whilst fundraising for those living with Leukaemia by taking on one of our adrenaline challenges!

Health Technology Appraisals

This involves working with bodies such as the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group (AWMSG) to ensure that the views of patients are taken into account when making decisions over access to drugs and treatments.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

April 23rd

Cost of leukaemia – Tony Pullen on sick pay

Tony Pullen talks openly about how being diagnosed with hairy cell leukaemia (HCL) has impacted his financial stability. ...

April 11th

Approval for the first CAR-T treatment for ALL is renewed

CAR-T therapy, tisagenlecleucel, has been given long term approval to be used on the NHS in England, thanks to a decision made by the National Institute for Health and Care Excellence's (NICE). ...

March 11th

NEW oral treatment for AML patients approved in Scotland

Leukaemia Care are pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patient with an IDH1 mutation who are ineligible for standard induction chemotherapy now have access to ivosidenib with azacitidine thanks to the decision made by the Scottish Medicines Consortium (SMC) today....